Snapdragon Chemistry CEO Matt Bio talks continuous manufacturing in drug development on Biotech 2050

Updated: Feb 2, 2021

Matt Bio, CEO of Snapdragon Chemistry discusses how continuous manufacturing is reshaping modern process development on the Biotech 2050 podcast. Read more or listen to the podcast at Biotech 2050 .

 

87 views0 comments